Alexion Pharmaceuticals

Alexion Pharmaceuticals Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Alexion Pharmaceuticals key operating metrics including Products, environmental, and social and governance score (ESG).

Products

25.0%

Q1, 2021

Neurology Patients (US)

2.6K

37.3%

FY, 2020

Facilities Owned, sq. ft.

240K

FY, 2020

Operating Metrics

Metrics	FY, 2018	FY, 2019	FY, 2020
Products	4	4	5
Neurology Patients (US)	788	1.9K	2.6K
Facilities Owned, sq. ft.	310K	240K	240K
Facilities Leased, sq. ft.	453K	413K	413

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub